Provided by Tiger Trade Technology Pte. Ltd.

REVVITY INC

83.90
-3.2200-3.70%
Post-market: 83.900.00000.00%16:34 EDT
Volume:835.25K
Turnover:70.48M
Market Cap:9.38B
PE:40.56
High:87.86
Open:86.69
Low:83.80
Close:87.12
52wk High:118.30
52wk Low:81.36
Shares:111.80M
Float Shares:106.00M
Volume Ratio:0.91
T/O Rate:0.79%
Dividend:0.28
Dividend Rate:0.33%
EPS(TTM):2.07
EPS(LYR):2.07
ROE:3.22%
ROA:2.22%
PB:1.29
PE(LYR):40.56

Loading ...

S&P 500 Futures Decline In Premarket Trading; L3Harris Technologies, Revvity Lead

Dow Jones
·
Jan 13

Revvity Stock Jumps on Profit Outlook Hike. Why the Shares Are at a Crossroads. -- Barrons.com

Dow Jones
·
Jan 13

BUZZ-Revvity rises as co expects to exceed 2025 profit forecast

Reuters
·
Jan 13

Revvity Preliminary Q4 Revenue Tops Estimates; Shares Rise After Hours

MT Newswires Live
·
Jan 13

Health science firm Revvity's preliminary Q4 revenue beats estimates

Reuters
·
Jan 13

Revvity to Hold Earnings Call on Monday, February 2, 2026; Provides Update on Financial Performance

THOMSON REUTERS
·
Jan 13

Revvity Inc - Full Year Adj EPS Expected to Exceed the Upper-End of $4.90-$5.00 Guidance

THOMSON REUTERS
·
Jan 13

Revvity Q4 Revenue USD 772 Million VS. Ibes Estimate USD 763.8 Million

THOMSON REUTERS
·
Jan 13

Why Revvity (RVTY) Is Up 6.4% After New Lilly AI Drug Discovery Partnership Integration

Simply Wall St.
·
Jan 12

Revvity Partners with Lilly to Expand Access to AI Drug Discovery Models

Reuters
·
Jan 09

Revvity Inc: Collaboration Funds Participating Biotechs to Access Lilly Predictive Models Through Revvity Signals Xynthetica Offering

THOMSON REUTERS
·
Jan 09

Revvity Collaborates With Lilly to Expand Access to AI Drug Discovery Models

THOMSON REUTERS
·
Jan 09

Revvity CEO to Present Strategic Update at J.P. Morgan Healthcare Conference

Reuters
·
Dec 18, 2025

Revvity Launches Signals Xynthetica AI Platform for Molecular and Materials Discovery

Reuters
·
Dec 16, 2025

Revvity Shares Fall After BofA Downgrade

MT Newswires Live
·
Dec 16, 2025

BofA Securities Downgrades Revvity to Neutral From Buy

MT Newswires Live
·
Dec 15, 2025

Revvity Inc : Bofa Global Research Cuts to Neutral From Buy; Raises Price Objective to $110 From $105

THOMSON REUTERS
·
Dec 15, 2025

Revvity Inc. Stock Rallies 4.8%, Outperforms Peers

Dow Jones
·
Dec 11, 2025

VolitionRx Nu.Q NETs Assay Selected for French Sepsis Detection Study

Reuters
·
Dec 04, 2025

Revvity Inc. Stock Rallies 5.0%, Outperforms Peers

Dow Jones
·
Nov 26, 2025